Inventor
MAN HON-WAH
US129 patents
⚠️ This page may combine multiple inventors who share the name “MAN HON-WAH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
39 patentsUS7244759B2Jul 17, 2007
Isoindoline compounds and methods of making and using the same
CELGENE CORP138 citations99
US7091353B2Aug 15, 2006
Isoindole-imide compounds, compositions, and uses thereof
CELGENE CORP147 citations99
US6962940B2Nov 8, 2005
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
CELGENE CORP107 citations99
US6020358AFeb 1, 2000
Substituted phenethylsulfones and method of reducing TNFα levels
CELGENE CORP296 citations99
US6011050AJan 4, 2000
Substituted phenethylsulfones and method of reducing TNFα levels
CELGENE CORP172 citations99
US5955476ASep 21, 1999
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
CELGENE CORP267 citations99
US5874448AFeb 23, 1999
Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
CELGENE CORP285 citations99
US7893101B2Feb 22, 2011
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
CELGENE CORP44 citations98
US7635700B2Dec 22, 2009
5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same
CELGENE CORP78 citations98
US6667316B1Dec 23, 2003
Pharmaceutically active isoindoline derivatives
CELGENE CORP88 citations98
US6326388B1Dec 4, 2001
Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
CELGENE CORP115 citations98
US7427638B2Sep 23, 2008
(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof
CELGENE CORP53 citations97
US7659303B2Feb 9, 2010
Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dione
CELGENE CORP21 citations96
US7659302B2Feb 9, 2010
Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione
CELGENE CORP35 citations96
US7507759B2Mar 24, 2009
Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione
CELGENE CORP21 citations96
US7358272B2Apr 15, 2008
Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione
CELGENE CORP21 citations96
US6911464B2Jun 28, 2005
N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP41 citations96
US6214857B1Apr 10, 2001
Substituted alkanohydroxamic acids and method of reducing TNFα levels
CELGENE CORP76 citations96
US9724330B2Aug 8, 2017
Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CELGENE CORP7 citations93
US9499514B2Nov 22, 2016
Antiproliferative compounds and methods of use thereof
CELGENE CORP28 citations93
US9283207B2Mar 15, 2016
Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CELGENE CORP7 citations93
US9018243B2Apr 28, 2015
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
CELGENE CORP13 citations93
US8802717B2Aug 12, 2014
Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
CELGENE CORP13 citations93
US7820697B2Oct 26, 2010
Compositions and method for reducing TNFα levels
CELGENE CORP27 citations93
US7405237B2Jul 29, 2008
Isoindoline compounds and methods of their use
CELGENE CORP12 citations93
US6656964B2Dec 2, 2003
Method of inhibiting phosphodiesterases with substituted alkanohydroxamic acids
CELGENE CORP18 citations93
US10357489B2Jul 23, 2019
Antiproliferative compounds and methods of use thereof
CELGENE CORP20 citations92
US9828361B2Nov 28, 2017
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP12 citations92
US8012997B2Sep 6, 2011
Isoindole-imide compounds, compositions, and uses thereof
CELGENE CORP30 citations92
US7576104B2Aug 18, 2009
Isoindole-imide compounds, compositions, and uses thereof
CELGENE CORP24 citations92
US7511072B2Mar 31, 2009
7-amido-isoindolyl compounds and methods of its use
CELGENE CORP16 citations92
US7256210B2Aug 14, 2007
7-amido-isoindolyl compounds and methods of their use
CELGENE CORP24 citations92
US7173058B2Feb 6, 2007
Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP20 citations92
US7034052B2Apr 25, 2006
7-Amido-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP32 citations92
US6762195B2Jul 13, 2004
Pharmaceutically active isoindoline derivatives
CELGENE CORP29 citations92
US6699899B1Mar 2, 2004
Substituted acylhydroxamic acids and method of reducing TNFα levels
CELGENE CORP45 citations91
US10092542B2Oct 9, 2018
Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CELGENE CORP4 citations84
US9920027B2Mar 20, 2018
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP4 citations84
US9822094B2Nov 21, 2017
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP9 citations84
MULLER GEORGE W
3 patentsUS8455536B2Jun 4, 2013
Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
MULLER GEORGE W28 citations96
US8629173B2Jan 14, 2014
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
MULLER GEORGE W11 citations92
US8093283B2Jan 10, 2012
Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereof
MULLER GEORGE W17 citations92
MULLER GEORGE
2 patentsSIGNAL PHARM LLC
2 patentsUS9814713B2Nov 14, 2017
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
SIGNAL PHARM LLC14 citations92
US9365524B2Jun 14, 2016
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
SIGNAL PHARM LLC22 citations92
(unassigned)
1 patentMAN HON-WAH
1 patentRUCHELMAN ALEXANDER L
1 patentUNIV WASHINGTON
1 patentShowing the top 50 of 129 patents by PatentIndex Score.